Alessandro S De Nadai1,2,3, Marc S Karver3, Tanya K Murphy1,2, Mark A Cavitt2,4, Jeffrey L Alvaro2,4, Michael Bengtson5, Saundra Stock2, Andrew C Rakhshani3, Eric A Storch1,2,3,4,6. 1. 1 Department of Pediatrics, Rothman Center for Pediatric Neuropsychiatry, University of South Florida Morsani College of Medicine , Tampa, Florida. 2. 2 Department of Psychiatry, University of South Florida , Tampa, Florida. 3. 3 Department of Psychology, University of South Florida , Tampa, Florida. 4. 4 All Children's Hospital-Johns Hopkins Medicine , St. Petersburg, Florida. 5. 5 James A. Haley Veterans' Hospital , Tampa, Florida. 6. 6 Rogers Behavioral Health -Tampa Bay, Tampa, Florida.
Abstract
OBJECTIVE: The purpose of this article is to review the literature on hypothesized behavioral correlates of pharmacotherapy treatment response. A particular focus is placed on what have been referred to as "common factors" across mental health treatments, including medication adherence, therapeutic alliance, motivation for behavior change, and expectancies for positive treatment outcomes. These understudied factors may provide unique explanations for mechanisms of symptom change, patient risk as a result of protocol deviation, and attenuated treatment outcomes. METHOD: A literature search was conducted to evaluate the relationship between treatment processes in pediatric psychiatry and medication adherence, therapeutic alliance, motivation for behavior change, and expectancies for positive treatment outcomes. RESULTS: Substantial variability and room for improvement was identified for each common factor. Behavioral protocols have already been developed to address many aspects of common factors in pediatric psychiatric treatment, but are not yet a part of many practice parameters. CONCLUSION: Interventions to improve common factors can be used immediately in tandem with psychopharmacological interventions to provide increased symptom relief and reduce patient risk. Furthermore, incorporating instruction in common factors interventions can positively affect training of future providers and enhance understanding of the mechanisms of effect of medications. An increased focus on common factors, with a particular emphasis on quantifying the magnitude and mechanisms of their effects on psychopharmacological interventions stand to benefit child patients, their families, treatment providers, training facilities, and pharmaceutical manufacturers.
OBJECTIVE: The purpose of this article is to review the literature on hypothesized behavioral correlates of pharmacotherapy treatment response. A particular focus is placed on what have been referred to as "common factors" across mental health treatments, including medication adherence, therapeutic alliance, motivation for behavior change, and expectancies for positive treatment outcomes. These understudied factors may provide unique explanations for mechanisms of symptom change, patient risk as a result of protocol deviation, and attenuated treatment outcomes. METHOD: A literature search was conducted to evaluate the relationship between treatment processes in pediatric psychiatry and medication adherence, therapeutic alliance, motivation for behavior change, and expectancies for positive treatment outcomes. RESULTS: Substantial variability and room for improvement was identified for each common factor. Behavioral protocols have already been developed to address many aspects of common factors in pediatric psychiatric treatment, but are not yet a part of many practice parameters. CONCLUSION: Interventions to improve common factors can be used immediately in tandem with psychopharmacological interventions to provide increased symptom relief and reduce patient risk. Furthermore, incorporating instruction in common factors interventions can positively affect training of future providers and enhance understanding of the mechanisms of effect of medications. An increased focus on common factors, with a particular emphasis on quantifying the magnitude and mechanisms of their effects on psychopharmacological interventions stand to benefit childpatients, their families, treatment providers, training facilities, and pharmaceutical manufacturers.
Entities:
Keywords:
adherence; alliance; common factors; expectancies; motivation
Authors: S M Sotsky; D R Glass; M T Shea; P A Pilkonis; J F Collins; I Elkin; J T Watkins; S D Imber; W R Leber; J Moyer Journal: Am J Psychiatry Date: 1991-08 Impact factor: 18.112
Authors: Krystal M Lewis; Chika Matsumoto; Elise Cardinale; Emily L Jones; Andrea L Gold; Argyris Stringaris; Ellen Leibenluft; Daniel S Pine; Melissa A Brotman Journal: J Child Adolesc Psychopharmacol Date: 2020-03-11 Impact factor: 2.576
Authors: Lindsey D Cunningham; Eduardo F Salgado; Matthew C Aalsma; Jennifer M Garabrant; Julie K Staples; James S Gordon; Michelle P Salyers Journal: BMC Pediatr Date: 2021-10-27 Impact factor: 2.125
Authors: Lauren Kenworthy; Alyssa Verbalis; Julia Bascom; Sharon daVanport; John F Strang; Cara Pugliese; Andrew Freeman; Charlotte Jeppsen; Anna C Armour; Geneva Jost; Kristina Hardy; Gregory L Wallace Journal: Autism Date: 2021-07-09